Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease: A Multi-center Single-arm Study in China
Phase of Trial: Phase IV
Latest Information Update: 24 Aug 2017
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Acronyms STDMMAD
- 15 Aug 2017 Planned number of patients changed from 1000 to 554.
- 15 Aug 2017 Status changed from not yet recruiting to recruiting.
- 04 Jun 2016 New trial record